Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
My only question is .... why does he announce this on his Facebook page and not via press release where all shareholders have access? Opening up a new location in a foreign country is a big deal to shareholders - or at least to me it is.
Long.
cc73
I am linked to him Victor Dermatology & Rejuvenation ... on Facebook but can't find his post you mention.
I can't see it either. .. can you post link or quote.
Thanks. Long. Canitocano73
March is right around the corner. .. Andrews it Is. ;)
Long.
Canitocano73
We still have time for a press release from Victor this week. Update your shareholders Dr. Victor - it goes a long way.
Long.
Canitocano73
Everything is possible.
Long.
Canitocano73
We are true longs here, Uncle Rico. My past experience in the market instructs me to ride this one out. Up, Up and away!!!
Long.
cc73
I don't know about this summer but this ticker has an unbelievable potential. So, I am going long and still accumulating.
Cc73
I don't know about this summer but this ticker has an unbelievable potential. So, I am going long and still accumulating.
Cc73
My original purchases were in the .074 -.076 range.... Patience , time, and money have allowed me to average down into the trips arena. Patience pays.
Long.
Canitocano73
Another next week would certainly assist with the continuation of this positive vibe that has filled our room. It's all in the pr's!
Psyched about my purchase this week - next week I'll be loading again.
Long.
Canitocano73
I believe those are trip 3'S I see around the corner. It may not be long before trip 1's and 2's are a thing of the past. More news next weeks? Perhaps.
Long.
cc73
I just picked up a few mill at a deuce today... Long baby.
Cc73
I SMELL MONEY IN NEAR FUTURE...
LONG,
CC73
Diabetes to Invigorcell
PR Newswire
January 27, 2015: 11:30 AM ET
NEW YORK, Jan. 27, 2015 /PRNewswire/ -- IntelliCell BioSciences, Inc. ("IntelliCell" or the "Company") (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous stromal vascular cells (SVCs) derived from the blood vessels found in adipose tissue, today announced a license agreement for the indication of Diabetes Mellitus.
Invigorcell will be filing an IND with the FDA for the indication of Diabetes Mellitus.
According to Dr. Steven Victor CEO, "We are pleased to license the indication of Diabetes Mellitus to Invigorcell who will be conducting an IND with the FDA. With Joe Krivulka and Marc Sandberg MD leading the way I am sure we will see positive results with the FDA in a short period of time, and be able to change the lives of millions of diabetic patients."
Marc Sandberg, M.D., "Diabetes has both a huge financial and personal burden around the world. Restoring both Beta Cell and Metabolic function using Stromal Vascular Fraction Cells derived from blood vessels found in adipose tissue has a great potential to relieve suffering of people and improve economies."
About IntelliCell BioSciences
IntelliCell is a pioneering regenerative medicine company focused on the expanding regenerative medical markets using adult autologous stromal vascular fraction cells (SVFCs) derived from the blood vessels in the adult adipose tissue. IntelliCell BioSciences has developed its own patented technology and protocol to separate adult autologous vascular cells from adipose tissue without the use of enzymes. IntelliCell will also be seeking to develop technology-licensing agreements with technology developers, Universities, and international business entities.
About Invigorcell
Invigorcell is a biotech company that will utilize the technologies of IntelliCell BioSciences to develop innovative treatments for the normalization of metabolism in both Type 1 and Type 2 diabetes. Invigorcell is lead by Marc I. Sandberg, MD, FACP, CDE and Joe Krivulka.
Dr. Sandberg is a Clinical Assistant Professor in the Department of Internal Medicine at Temple University School of Medicine and is a certified diabetes Educator and board certified in Endocrinology, Diabetes and Metabolism. He is the medical director for the Center for Nutrition at Hunterdon Medical Center in Flemington, NJ. He practices general endocrinology and diabetes, and was recognized as a New Jersey Top Doc in 2005 and 2011-14. He has been involved in numerous Phase II-IV pharmaceutical trials, has served on several diabetes advisory product boards and lectures widely on diabetes.
Mr. Joseph J. Krivulka is Independent Director at Dance Biopharm, Inc., Chairman at Rouses Point Pharmaceuticals LLC, Chairman & Chief Executive Officer at Akrimax Pharmaceuticals LLC, and Independent Director at Nektar Therapeutics. Mr. Krivulka was previously employed as Chief Executive Officer by Triax Pharmaceuticals LLC, Independent Director by Aeolus Pharmaceuticals, Inc., President by Reliant Pharmaceuticals LLC, Chief Executive Officer by Bertek, Inc., and Vice President by Mylan Laboratories, Inc. He also served on the board at Ambrilia Biopharma, Inc., Biovail Corp., and Incara Pharmaceuticals Corp. He received his undergraduate degree from West Virginia Wesleyan College.
Forward-Looking Statements
Certain statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "will reach," "will change," "will soon," "should," "could," "would," "may," "can" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.
Contact:
IntelliCell BioSciences, Inc.
Investor Relations
Anna Rhodes
arhodes@intellicellbiosciences.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/intellicell-biosciences-licenses-indication-for-diabetes-to-invigorcell-300026319.html
SOURCE IntelliCell BioSciences, Inc.
There is absolutely NO LOGICAL reason to suggest such action by the company. It is a mere attempt to continue to rattle the nerves of any weak shareholders left. Going long.
LONG.
CC73
Congratulations to you and your lovely wife. Longs are always ready!!!
Long.
cc73
A second press release would hit the spot this morning. Victor, hit the send button. Those who want to sell should be gone by now - no point in "suffering." I'm ready for good news and upward movement. Good luck to everyone.
Long.
cc73
Click5 are you stating this as fact?
Long.
cc73
Alright, who is the big spender here? Who bought the 1 share? That's a classic. Can I get some news please? Go Vic!!!
long.
cc73
Good morning my fellow shareholders. Just popped in to say hello - while we wait for good news. Now back to business. Good luck to everyone.
Long.
cc73
Gannicus, me , you, Shish, Shivas38 and a handful of others here have clutched a nice percentage of the O/S. There are a few other nickel and dimers out there that parked a few "just in case" bucks. The heads all have shares- why sell now? Not a chance. I have a few more buys to make before I call it enough. ;)
Long.
Canitocano73
Titan, I spent a lot of money at .076 .... I have averaged down quite a bit but I'll continue to accumulate. ... i am a very patient investor. Long.
Canitocano73
The sky has not fallen and the earth is still supporting my chair as I await the unveiling of the PLAN. These are exciting times - if you really pay attention. Back to my chair.
LONG.
CC73
I am riding thus ticker all the way to the bank!!! They can't have mine!!!!
Long.
Canitocano73
Feliz Navidad y Un Propero Ano Nuevo to all my fellow SVFC SHAREHOLDERS.
long.
cc73
300 mill on the bid side. I am pulling up a chair, sitting back and letting this play out a bit. I like surprises.
I am LONG.
cc73
This decision has be part of a bigger plan otherwise I can't see the 250B a/s. They could have raised it by another 5 or 10 b and "hustled" shareholders like many here would like u to think. Going long.
Long.
Canitocano73
Being the day before Christmas, I highly doubt that the good Doc decided to wait for such a holiday to drop a negative bomb on shareholders. There has to be more than meets the eye. Patience.
GLTU.
LONG
Cc73
I got the same response after emailing her a few times last week.
Long.
cc73
Send him a text message ; )
Highly doubt it. Easy.
4AM meeting is a bit too early for me. Sounds serious.
LONG .
CC73
I'll be a buyer again in a few days...powder has to clear. Looking at the bid & ask sides tells me that one positive announcement and the run will begin. Adding while I still can at these levels . Good luck to everyone.
Long.
Canitocano73
Far from zero bid.
:)
Long.
cc73
Gonia, I've been a buyer for close to 18 months now. Time is what this ticker needs.
Long.
Canitocano73
My funds will be in my accounts then.